Depression is linked to dry eye disease symptoms in elderly patients

Article

A paper published in Investigative Ophthalmology and Visual Science has revealed an association between dry eye disease (DED) and depression in patients with a normal or slightly reduced tear production.

A paper published in Investigative Ophthalmology and Visual Science has revealed an association between dry eye disease (DED) and depression in patients with a normal or slightly reduced tear production.

The investigation led by Dr Joon Young Hyon, Department of Ophthalmology, Seoul National University Bundang Hospital, Korea, examined 657 Korean patients aged 65 years and over. A six-item Dry Eye Questionnaire was used to assess DED symptoms. The Schirmer test, fluorescein stain score and tear film break-up time (BUT) was used to evaluate DED signs. The Korean equivalent of the Short Geriatric Depression Scale (SGDS-K) was used to identify depression.

Binary logistic linear analysis highlighted the female sex, living in an urban area and a Schirmer score of less than 5 mm as factors contributing towards the risk of developing DED.

Depression was not affected by DED patients with a Schirmer score of less than 5 mm, but was affected by a Schirmer score of more than 5 mm. SGDS-K score was associated with several positive answers in the Dry Eye Questionnaire.

Recent Videos
Patrick C. Staropoli, MD, discusses clinical characterisation of Hexokinase 1 (HK1) mutations causing autosomal dominant pericentral retinitis pigmentosa
Richard B. Rosen, MD, discusses his ASRS presentation on illuminating subclinical sickle cell activities using dynamic OCT angiography
ASRS 2024: Socioeconomic barriers and visual outcomes in patients with rhegmatogenous retinal detachments, from Sally S. Ong, MD
Ashkan Abbey, MD, speaks about his presentation on the the CALM registry study, the 36-month outcomes of real world patients receiving fluocinolone acetonide 0.18 mg at the annual ASRS meeting in Stockholm, Sweden.
Nikoloz Labauri, MD, FVRS, speaks at the 2024 ASRS meeting about suspensory macular buckling as a novel technique for addressing myopic traction maculopathy
Jordana Fein, MD, MS, speaks with Modern Retina about the IOP outcomes with aflibercept 8 mg and 2 mg in patients with DME through week 48 of the phase 2/3 PHOTON trial at the annual ASRS meeting in Stockholm, Sweden.
John T. Thompson, MD, discusses his presentation at ASRS, Long-Term Results of Macular Hole Surgery With Long-Acting Gas Tamponade and Internal Limiting Membrane Peeling
ASRS 2024: Michael Singer, MD, shares 100-week results from the RESTORE trial
© 2024 MJH Life Sciences

All rights reserved.